TrialMedical oncology (Northwood, London, England)2018

ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer.

Matthias Villalobos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.